Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions by Vicente Rodríguez, Juan Carlos de et al.
Med Oral Patol Oral Cir Bucal. 2010 Sep 1;15 (5):e709-15.                                                                                                                                   Comparative study of the odontogenic keratocysts
e709
Journal section: Oral Medicine and Pathology                                                                                                              doi:10.4317/medoral.15.e709
Publication Types: Research
Immunohistochemical comparative study of the odontogenic keratocysts 
and other odontogenic lesions
Juan-Carlos de-Vicente 1, Aintzane  Torre-Iturraspe 1, Ana-María Gutiérrez 2, Paloma Lequerica-Fernández 3
1 Department of Oral and Maxillofacial Surgery (Head: Prof. Dr. Juan Sebastián López-Arranz, M.D., Ph.D.)
2 Department of Pathology (Head: Prof. Dr. Manuel F. Fresno, M.D., Ph.D.)
3 Instituto Universitario de Oncología del Principado de Asturias (Head: Prof. Dr. Carlos Suárez-Nieto, M.D., Ph.D.). Univer-
sity Central Hospital of Asturias and Faculty of Medicine, Oviedo, Asturias, Spain
Correspondence: 
Servicio de Cirugía Oral y Maxilofacial
Hospital Universitario Central de Asturias
C/ Celestino Villamil s/n. 






Objectives: The present study was undertaken to compare the pattern of expression of EGFR, cyclin D1, Ki-67, 
p-53 and carcinoembryonic antigen (CEA) in the epithelial lining of odontogenic keratocysts, dentigerous cysts, 
radicular cysts and ameloblastomas.
Methods: four micrometers, formalin-fixed, paraffin-embedded tissue sections from 11 odontogenic keratocysts, 
10 dentigerous cysts, 10 radicular cysts and 10 ameloblastomas were immunohistochemically studied.
Results: There were statistically significant differences between cyclin D1 expression in odontogenic keratocysts 
and radicular cysts (p= 0.001) and ameloblastomas (p= 0.04). The differences in CEA expression between the four 
studied lesions were statistically significant (p< 0.0005). Proliferating cells were significantly more prevalent in 
odontogenic keratocysts (p< 0.0005) with a mean percentage of Ki-67 positively stained nuclei of 40%. In denti-
gerous cysts this mean was of 17%, of 15.5% in RC and of 7.8 in ameloblastomas.
Conclusion: Some of these findings could support the theory that odontogenic keratocysts are neoplastic in ori-
gin, but other results clearly support that these lesions are developmental cysts with some neoplastic properties 
because of the high intrinsic growth potential.
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Introduction
Different types of odontogenic cysts and tumors arise 
from derivates of embryologic dental lamina. The po-
tential for further proliferation of these epithelial rem-
nants during formation of a cyst is different and thus 
lead to variations in their molecular expression and 
biological behaviour, due to an underlying mechanism 
that remains highly speculative. Three major categories 
of odontogenic cysts are usually distinguished: radicu-
lar cysts (RCs), follicular or dentigerous cysts (DCs), 
and keratocysts. Keratocysts accounts for 3% to 11% 
of odontogenic cysts (1) and it is well known that they 
show aggressive behaviour with higher rates of recur-
rence than other types of odontogenic cysts, as well as 
a tendency to invade adjacent tissue (1). Odontogenic 
keratocysts (OKCs) can arise sporadically or, about 4 to 
5% of them (2), in association with the nevoid basal cell 
carcinoma syndrome (Gorlin syndrome) in which case 
the clinical behaviour of OKCs is even more aggres-
sive. This aggressive biological behavior of the OKCs 
and its tendency to recurrence might be associated with 
cell kinetics in the lining epithelium. Numerous reports 
focusing on the greater proliferative potential of the epi-
thelial lining of OKCs, showing a high mitotic index (3) 
compared with other types of odontogenic cysts. Con-
sequently, it has given rise to the hypothesis that odon-
togenic keratocysts may represent benign neoplasms 
instead of odontogenic cysts.
Cell kinetics is under the influence of growth factors 
such as the peptide Epidermal Growth Factor (EGF) and 
its receptor (EGFR). EGFR distribution is observed in 
normal epithelium, mainly in proliferating basal cells, 
and is expressed most intensely in both benign and ma-
lignant epithelial neoplasms. Interestingly, EGF and 
EGFR might provide epigenetic control of odontogen-
esis by modulating cell growth and cell interaction (4). 
Since the majority of human neoplasms are character-
ized by an imbalance of the regulatory cell cycle con-
trol process, the study of proto-oncogenes and tumor 
suppressor genes, such as cyclin D1 and p53, involved 
in critical check-points of cell growth could improve 
our knowledge about the biological substrate of OKCs 
behaviour.  Ki-67 antigen is a protein expressed in all 
phases of the cell cycle, except in G0.  Its expression 
increases with cell cycle progression, rising during the 
latter half of the S phase, reaching a peak in the G2 and 
M phase and rapidly decreasing after mitosis. Thus Ki-
67 expression informs about the number of proliferating 
cells in a tissue. 
Tumor markers, usually proteins, are produced by the 
body in response to a tumor or by the tumor tissue itself. 
The tumor marker carcinoembryonic antigen (CEA) 
has been detected in many cancers, as well as in odon-
togenic tumors and keratocysts (5), but its significance 
in the latter is unclear. All of the above mentioned gene 
products have been studied in odontogenic keratocysts, 
and have been related to their aggressive nature, but the 
results are inconclusive.
Based on the hypothesis that odontogenic keratocysts 
are true neoplasms, the present study was undertaken 
to characterize the pattern of expression of EGFR, cy-
clin D1, Ki-67, p-53 and CEA in the epithelial lining of 
odontogenic keratocysts, and two other cysts and a true 




After reviewing clinical information and histology, 
cases of parakeratinized odontogenic keratocyst (n= 
11), dentigerous cyst (n= 10), radicular cyst (n= 10) and 
ameloblastoma (n= 10) were selected from the files of 
the Departments of Oral and Maxillofacial Surgery and 
Pathology, Hospital Universitario Central de Asturias, 
Spain, from January 1994 to July 2000. Inclusion cri-
teria were surgical treatment performed according to 
standard procedures and consisting of the resection of 
the cyst or tumor, complete clinical and histopathologic 
data and availability of sufficient tissue material. None 
of the odontogenic keratocysts were associated with the 
nevoid basal cell carcinoma syndrome.
Antibodies
Antibodies used in this study are listed in (Table 1).
Immunohistochemical study 
All selected cases had been routinely fixed in 10% neu-
tral formalin (pH 7.4) for 72h and embedded in paraffin. 
Antibodies Source Clones Dilutions Specificity
EGFR Dako, Carpinteria, CA H11 1:50 Transmembranous receptor of EGFR
CEA Dako, Glostrup, Denmark II-7 1:50 Carcinoembryonic antigen
p53 Dako, Carpinteria, CA D07 1:100 P53 protein 
Cyclin D1 Neo Markers SP4 1:50 Cyclin D1
Ki67 Dako, Carpinteria, CA MIB-1 1:100 Nuclear antigen Ki-67 
Table 1. Antibodies employed in this study.
All these antibodies are Mouse monoclonal with the only exception of Cyclin D1 that is rabbit polyclonal.
Med Oral Patol Oral Cir Bucal. 2010 Sep 1;15 (5):e709-15.                                                                                                                                   Comparative study of the odontogenic keratocysts
e711
In ameloblastomas, decalcification of the specimen was 
performed in 10% formic acid for 48 to 72 h. Four-µm-
thick tissue sections were mounted on poly-L-lysine-
coated slides and treated in a routine way. The sections 
were then heated in 10mM citrate buffer (pH 6.5) for 4 
min in a microwave oven at 500W to retrieve antigenic-
ity. Non-specific conjugation was blocked with a solu-
tion of 20% rabbit serum (DAKO, Glostrup, Denmark) 
applied to the sections for 10 min.
Immunohistochemistry was performed incubating the 
sections with primary antibodies against EGFR, cyclin 
D1, Ki-67, p53 and CEA for 30 minutes at room temper-
ature. They were then rinsed in PBS, and bound anti-
body was detected using EnVision polymer technology 
(K4001, DAKO, Carpinteria, CA) for 30 min according 
to the manufacturer’s instructions. After washing in 
PBS, staining was developed with 3, 3’-diaminobenz-
idine-tetrahydrochloride in 50mM Tris–HCL (pH 7.5) 
containing 0.001% hydrogen peroxide for 5min, and 
then lightly counterstained with Mayer’s hematoxylin. 
All slides were independently reviewed by two inves-
tigators.
The EGFR expression was scored varying from 0 to 2+ 
(0 was defined as being negative and 1+ and 2+ as being 
positive and intense, respectively). Staining for Ki-67 
was measured as the percentage of positively stained 
nuclei (proliferation index) in 200 epithelial cells in 
a consecutive field. We scored the cyclin D1 and p53 
expression according to three categories: negative (ab-
sence of staining) and positive, and this latter into two 
additional categories, focal or diffuse staining.  Finally, 
CEA expression was assessed as negative or positive.
Statistical analysis
Analysis of the data was performed using SPSS soft-
ware, version 14.0. The χ2 test was used for comparisons 
of categorical variables and the Kruskal-Wallis test for 
continuous variables. Two-sided p values are reported 
at a significance level of p equal or less than 0.05.
Results
The expression of EGFR, CEA, p53 and cyclin D1 is 
summarized in (Table 2). EGFR expression was positive 
in 100% of ameloblastomas, 73% of the OKCs, 40% of 
dentigerous cysts and 30% of radicular cysts. In nine 
cases of ameloblastomas EGFR stain was diffuse, while 
in one case the reaction was focally located. In odonto-
genic keratocysts EGFR immunostaining was located 
in the basal cell layer, and was focal in eight and diffuse 
in no one case (Fig. 1). In all positive dentigerous and 
radicular cysts, immunostaining was focal. In all posi-
tive specimens cytochemical localization of EGFR was 
of the cell membrane positive type.
Immunostaining for cyclin D1 was positive in 50% of 
DCs, 30% of RCs, 40% of ameloblastomas, and 91% of 
OKCs. In almost all OKCs, cyclin D1 was expressed in 
a focal parabasal pattern (Fig. 2A), while in DCs and in 
RCs focal and diffuse patterns were equally observed. 
In all positive ameloblastomas, the staining pattern was 
only diffuse. P53 immunoexpression was positive in 
64% of OKCs, 40% of DCs and RCs, and 30% of amelo-
Lesion
EGFR Cyclin D1 P53 CEA
0 (%) 1+ (%) 2+ (%) 0 (%) Focal (%) Difuso (%) 0 (%) Focal (%) Difuso (%) - (%) + (%)
OKCs 3 (27) 8 (73) 0 (0) 1 (9) 9 (82) 1 (9) 4 (36) 6 (55) 1 (9) 0 (0) 11 (100)
DCs 6 (60) 4 (40) 0 (0) 5 (50) 3 (30) 2 (20) 6 (60) 2 (20) 2 (20) 7 (70) 3 (30)
RCs 7 (70) 3 (30) 0 (0) 7 (70) 2 (20) 1 (10) 6 (60) 2 (20) 2 (20) 10 (100) 0 (0)
Am 0 (0) 1 (10) 9 (90) 6 (60) 4 (40) 0 (0) 7 (70) 3 (30) 0 (0) 10 (100) 0 (0)
Tabla 2. EGFR, Cyclin D1, P53 and CEA staining [number and percentage]  in odontogenic keratocysts (OKS), dentigerous cysts (DCs), 
radicular cysts (RCs), and ameloblastomas (Am).
EGFR: Am vs OKCs, DCs, y RCs: p < 0,0005. Cyclin D1: OKC vs DCs: p = 0,08; OKCs vs RCs: p= 0,01; OKCs vs Am: p= 0,04. CEA: OKCs 
vs DCs; OKCs vs RCs y OKCs vs Am: p< 0,0005.
Fig. 1. Positive expression of EGFR in an odontogenic keratocist. 
Staining is located to the cell membrane and extending from basal 
to superficial cells in cyst lining (Original magnification, x 400).
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blastomas. Immunolabelling for P53 was observed in 
the nuclei of cells scattered in the whole lining epithe-
lium of OKCs, but mainly basally (Fig. 2B). In DCs and 
in RCs, P53 protein immunoexpression was located in 
the basal cell layer, and in ameloblastomas its expres-
sion was scattered and only occasionally clustered.
Almost all cases (19 of 20) of OKCs and only three of 
ten dentigerous cysts were immunoreactive with CEA 
antibody. On the other hand, no cases of radicular cysts 
or ameloblastomas showed CEA immunoreactivity. 
CEA immunoreactive cells showed two basic patterns of 
stain: diffuse staining throughout the cytoplasm and pe-
ripheral staining along the cell membrane (Fig. 3). Nei-
ther OKCs nor other two dentigerous cysts showed any 
staining within basal and parabasal epithelial cell layers. 
Conversely, CEA reactivity was consistently detected in 
mature cells located in superficial layers and was diffuse 
in all OKCs. In the three immunopositive dentigerous 
cysts the stain was also superficial and focal.
EGFR was significantly more common in ameloblastomas 
than in the three types of studied odontogenic cysts, be-
ing statistically significant differences with odontogenic 
keratocysts (p< 0.0005). There were statistically signifi-
cant differences between cyclin D1 expression in OKCs 
and in RCs (p= 0.01) and ameloblastomas (p= 0.04). The 
differences in CEA expression between the four studied 
lesions were statistically significant (p< 0.0005), with the 
only exception of radicular cysts and ameloblastomas 
that not were significantly different (p= 0.07). There were 
no significant differences between immunoexpression of 
P53 among the studied lesions(Table 2). 
Proliferating cells, detected by positive nuclear staining 
with Ki67, were most prevalent in OKCs with a mean 
percentage of positively stained nuclei of 40% (Figure 2 
C). In dentigerous cysts this mean was of 17%, of 15.5% 
in radicular cysts and of 7.8% in ameloblastomas. In od-
ontogenic keratocysts, Ki-67 staining was speckled and 
especially localized in the nuclei of basal and suprabas-
al cells. The cell proliferation index was significantly 
higher in OKCs than in the other lesions (p< 0.0005).
Fig. 2. Immunohistochemical expression of cell-cycle-related 
factors in lining epithelium of odontogenic keratocysts. (A) 
Positive staining for cyclin D1 in the nuclei of parabasal cells. 
(B) Reactivity for p53 in the nuclei of basal cells. (C) Immu-
nostaining for Ki-67. The Ki-67 immunopositive cells can be 
detected in the basal and intermediate layers of the lining epi-
thelium of cyst (Original magnification, x 400). Fig. 3. Positive staining for CEA in the epithelium of an 
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Discussion
The classification of odontogenic jaw cysts is based on 
their histology, pathogenesis and presumed develop-
mental origin. Radicular cysts have an epithelial lining 
derived from the epithelial rests of Malassez, follicular 
cysts developing by passive pooling of fluid beneath the 
crown follicle in association with impeded tooth erup-
tion and their epithelium is derived from reduced enam-
el epithelium. It is presumed that epithelia of OKCs 
originates from the odontogenic epithelium of the den-
tal lamina or its remnants, prior to tooth formation. 
However, it has also been suggested that odontogenic 
keratocysts could be derived from basal cells of the oral 
mucosa (6). Odontogenic keratocysts show a particular 
tendency to recur after their surgical removal that could 
be due to a multilocular nature or a presence of daughter 
or satellite cysts that are left behind. However, it has 
also been hypothesized that the epithelium of these cysts 
could have an intrinsic potential to growth, resembling 
benign neoplasms (7). Ameloblastomas are tumors that 
arise from rests of the dental lamina. Thus, OKCs and 
ameloblastomas derived from the same cell population, 
and like ameloblastomas, OKCs may behave aggres-
sively and can penetrate cortical bone, extending into 
the surrounding tissues, with also they show recurrence 
rates ranging from 3% to 60% (8). The EGF, a potent 
mitogen for epithelial cells, is important in the regula-
tion of proliferation in normal and neoplastic cells. EGF 
acts on target cells by binding to a specific cell surface 
receptor (EGFR) thereby stimulating a cellular protein 
kinase which catalyses the phosphorylation of tyrosine. 
This is the first step in a chain of reactions that culmi-
nate in mitosis (9). In this study, we have observed a 
trend of decreased staining positivity for EGFR in the 
following order: ameloblastomas (100%), OKCs (73%), 
dentigerous cysts (40%) and radicular cysts (30%). 
These results demonstrated that the epithelial cells of 
the aforementioned lesions express EGFR in variable 
patterns. In particular ameloblastomas and develop-
mental odontogenic cysts (OKCs and dentigerous cysts) 
exhibited more intense staining for EGFR than those 
of inflammatory radicular cysts that could probably be 
related with the biological aggressiveness of ameloblas-
tomas and OKCs. These results are in agreement with 
that of Li et al. (10), which found that ameloblastomas, 
odontogenic keratocysts, dentigerous cysts and radicu-
lar cysts were positive for EGFR, but contrast with 
Shrestha et al. (11), who separated primordial cysts from 
keratocysts for not explained reasons, and observed that 
60% and 75%, respectively, showed a positive EGFR 
reaction. Furthermore, the EGFR immunopositivity ob-
served in dentigerous cysts and radicular cysts was of 
47.4% and 35%, respectively, and in clear constrast with 
our results, they did not find EGFR positivity in any 
of 21 ameloblastomas studied. The transition between 
different cell cycle stages is regulated at several check-
points. Regulation of the G1-S transition is controlled 
by the Rb pathway proteins, which include, among oth-
ers, the cyclin D1 gene. The overexpression of this pro-
tein shows accelerated G1 progression entering in the 
S-phase of cell cycle, with lower cell dependence on 
growth factors for proliferation. Cyclin D1 may play an 
important role in tumorigenesis and it has been detected 
in malignant tumors but also in benign neoplasms. In 
the present study cyclin D1 was found in 91% of OKCs, 
and the rate of its expression was significantly higher 
than that of dentigerous cysts, radicular cysts and amel-
oblastomas. Conversely, Lo Muzio et al. (2) have found 
cyclin D1 overexpression in all OKCs associated with 
the Gorlin syndrome, while all sporadic odontogenic 
keratocysts on their study were negative. This differ-
ence, as well as we have observed with EGFR, is likely 
to be explained by differences in method. Regarding 
cyclin D1 expression, Lo Muzio et al. (2) used the clone 
5D4, diluted 1:800, while we used the clone SP4 at a 
1:50. We observed the cyclin D1 expression in a focal 
and basal pattern, as was also seen in dentigerous cysts 
and in radicular cysts. In all positive ameloblastomas, 
the staining pattern was only diffuse.
The mitotic index, immunohistochemically measured as 
Ki-67 positive cells, is greater in OKCs lining epithelium 
than in dentigerous and radicular cysts, and is similar to 
those seen in ameloblastoma or in actively growing den-
tal lamina (12,13). These differences in the proliferative 
activity of the OKCs epithelium are considered sugges-
tive of an intrinsic growth potential that could play a role 
in its biological behaviour (13,14). Similarly, an increased 
number of P53 positively stained cells have been found 
in the epithelium of OKCs in comparison with dentiger-
ous cysts and radicular cysts and its overexpression has 
been thought to result from overproduction and/or sta-
bilization of wild type P53 protein due to the increased 
proliferation of the epithelial cells (15). We have found 
that Ki-67 staining was principally speckled and espe-
cially localized in the nuclei of basal and suprabasal cells, 
which imply that cells of these layers posesses the highest 
proliferative activity in OKCs. In this study the cellular 
proliferation, measured by the expression of Ki-67, is 
higher in OKCs than in dentigerous ones. These findings 
suggest that in OKCs could exist a defective tumor sup-
pression function, that is reflected in a proliferative ac-
tivity higher than in ameloblastomas (p53 expression in 
odontogenic keratocysts and ameloblastomas was of 64% 
and 30%, respectively), as could be seen in the epithelial 
linings of the former.
On the other hand, a high proliferative index in OKCs 
could also be explained by the presence of inflamma-
tion in response of an infection or traumatism (16). Fur-
thermore, this high proliferative activity could decrease 
when inflammation decreases.
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The p53 gene, located at the short arm of chromosome 
17 is the best known tumor suppressor gene, and p53 
abnormalities are the most common genetic abnormali-
ties in human neoplasms. Wild-type p53 protein acts as 
a DNA-binding transcription factor and its activation 
elicits adaptative responses including growth arrest and 
apoptosis. Alterations of the p53 gene or inactivation of 
its protein product are usually involved in carcinogen-
esis, and tissues that express p53 seem to have a higher 
proliferative activity than p53-negative epithelia. Ogden 
et al. (17) found overexpression of p53 in odontogenic 
keratocysts associated with the nevoid basal cell carci-
noma syndrome, but studies correlating p53 and clin-
icopathological parameters in oral cysts have yielded 
different results. P53 protein has, in normal tissues, a 
very short half-life and cannot be detected with immu-
nohistochemical techniques, whereas the p53 mutation 
produces an increased stability. Mutation of p53 gene is 
a common finding in a wide range of human tumors and 
usually results in a more stable protein that accumulates 
in cells, allowing it to be detected immunohistochemi-
cally. Agaram et al. (8) found loss of heterozygosity in 
7 of 10 OKCs, being p53 one of the genes that most fre-
quently exhibited allelic losses (66%). However, muta-
tion of p53 gene is not only the reason why P53 protein 
remains longer in cells and can be detected. In addition, 
defects in protein degradation and binding to other pro-
teins, such as SV40, E1B, or HPVE6 viral proteins can 
also stabilize p53 protein in cells (18). 
In this study, p53 immunoexpression was positive in 
50% of OKCs, 40% of dentigerous cysts and radicular 
cysts, and 30% of ameloblastomas, but without statisti-
cally significant differences among them. Conversely, 
Piatelli et al. (19), also found a higher p53 expression in 
odontogenic keratocysts than in dentigerous and radicu-
lar cysts, and differences between the three groups were 
stastistically significant.  Ogden et al. (17) using CM-1 
antibody reported that 5 of 12 odontogenic keratocysts 
expressed P53, while Lombardi et al. (20)  with the same 
clone CM-1 found p-53 in 50% of their OKCs, including 
non-recurrent, recurrent and associated with the basal-
cell nevus syndrome. Piatelli et al. (19), employing the 
clone DO7 found p-53 expression in 45% of 20 odon-
togenic keratocysts. We have found the same percent-
age of positively stainded cells in OKCs as these authors 
on the contrary we have found higher positivity rates in 
dentigerous cysts and radicular cysts. It is not clear why 
benign lesions such as OKCs should express p53 protein 
at an immunohistochemically detectable level, but an 
expression of p53 for physiological reasons, such as pro-
tein’s normal function in DNA repair, could not be ex-
cluded. However, Slootweg (15) has found that amelob-
lastomas and odontogenic keratocysts presented a dense 
staining, whereas radicular and dentigerous cysts were 
faintly stained or negative, and he hypothesized that cell 
P53 positively stained could be related to increased pro-
liferation. Taken together, the high frequency of P53 ex-
pression and the higher mitotic activity in the epithelial 
lining of odontogenic keratocysts correlates well, and at 
least partially could explain the aggressive behaviour of 
odontogenic keratocysts consistent with that of benign 
tumors.
Howell et al. (5) studied the immunoexpression of car-
cinoembryonic antigen (CEA) in 7 odontogenic kera-
tocysts and in 19 ameloblastomas. They found that all 
cases of odontogenic keratocysts and 68% of amelob-
lastomas showed CEA immunoreactivity. Similarly, we 
have observed CEA immunoexpression in all OKCs, but 
conversely, none of our ameloblastomas showed reac-
tion against CEA. Howell et al. (5) stated that a possible 
explanation for CEA positive reaction could be due to 
a nonspecific cross-reaction with keratin. However, we 
have also studied the immunoexpression of pancytok-
eratin (Clones AE1/AE3, Dako, Carpinteria; dilution: 
1:400) in our OKCs and ameloblastomas and observed 
an immunoexpression both in all odontogenic kerato-
cysts and ameloblastomas (data not shown). Thus, the 
CEA expression probably reflects the aggressive nature 
of odontogenic keratocysts.
The immunohistochemical findings in the lesions inves-
tigated in the present study suggest that the biological 
behaviour of OKCs may be associated with deregula-
tion of cell cycle in the lining epithelium, indicated by 
increased expression of EGFR, cyclin D1, cell prolif-
eration and CEA. This supports the neoplastic nature 
of OKCs. However, they have shown important differ-
ences with the only neoplasm studied here, i.e. amelob-
lastomas. Thus, while 100% of the ameloblastoma cases 
reacted positively with EGFR, only 73% of odontogenic 
keratocysts did. On the other hand, the reverse was true 
in the case of cyclin D1, 91% of the cases of OKCs re-
acted positively and only 40% of ameloblastomas were 
reactive. Moreover, CEA stain was positive in 100% of 
OKCs cases but in none of the ameloblastomas. Further-
more, our results also show a fundamental difference 
between dentigerous and radicular cysts on the one hand 
and OKCs on the other hand in respect of their growth 
factor requirements and cell’s cycle control. Some of the 
findings of this study could contribute to support the 
neoplastic origin of OKCs. However, other results clear-
ly revealed that odontogenic keratocysts have also good 
resemblance with developmental odontogenic disorders 
as dentigerous and radicular cysts. Therefore, from an 
immunohistochemical point of view, OKCs could be 
seen as odontogenic neoplasms that show similarities 
with odontogenic cysts or as developmental cysts with 
some neoplastic properties because of the high intrinsic 
growth potential.
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